诺莫格拉姆可以预测子宫外怀孕中甲状腺素治疗的成功
Gil Zeevi1,2, Or Bercovich1,2, Yael Haring1,2
1Helen Schneider Hospital for Women, Rabin Medical Center, Petach Tikva, Israel.
概括
使用初始β-hCG水平和超声检查结果的预测模型可以预测管外宫妊娠的甲状腺素治疗成功,帮助临床决策.
科学领域:
- 生殖医学 生殖医学
- 妇科瘤学 妇科瘤学
- 临床药理学 临床药理学
背景情况:
- 输卵管外妊娠是怀孕早期的一个重要问题.
- 甲基 (MTX) 是一种常见的治疗方法,但成功率各不相同.
- 预测治疗结果对于有效的患者管理至关重要.
研究的目的:
- 确定预测单剂量甲状腺素治疗输卵管外妊娠成功的临床因素.
- 开发治疗结果的预测模型和名图.
主要方法:
- 对372名输卵管外妊娠患者进行了回顾性队列研究,这些患者接受了单剂量MTX治疗.
- 对预处理因素的分析,包括β-hCG水平和超声波参数.
- 后勤回归和多变量分析来构建一个预测模型.
主要成果:
- 单剂量MTX在77.9%的患者中实现了完全康复.
- 较低的初始β-hCG水平和没有黄囊/胎儿极的存在预测了成功.
- 开发的预测模型展示了准确性和区分能力.
结论:
- 基于初始β-hCG和超声波研究结果的预测性诺莫грам可以有效地预测单剂量MTX治疗成功的输卵管外妊娠.
- 这种工具可以帮助临床医生优化治疗策略.
更多相关视频
相关概念视频
Dosage Regimen Designs: Nomograms and Tabulations
Nomograms and tabulations are vital tools used by clinicians to design accurate and individualized dosage regimens. These instruments provide a straightforward method for adjusting dosages based on individual patient characteristics, including age, weight, and physiological condition. The foundation of a drug's nomogram is population pharmacokinetic data collected and analyzed using specific models. This data simplifies complex equations, presenting them diagrammatically or tabularly for easy...
Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...


